This review summarizes the currently known relationship between pancreatic cancer and the immune system and potential new treatment outcomes incorporating the immune system may be discovered.
Abstract
Simple Summary Pancreatic cancer is an aggressive disease and a leading cause of cancer-related deaths. Cells are able to undergo changes in the tumor, which is correlated with reduced efficacy of the immune system to target and destroy the tumor. This is a leading factor contributing to the severity of the cancer and requires further study. By understanding these factors, potential new treatment outcomes incorporating the immune system may be discovered. This review summarizes the currently known relationship between pancreatic cancer and the immune system.
Highlights • Cell death is a key biological process to maintain tissue homeostasis and prevent abnormal cell accumulation.• NETosis is mediated by the release of extracellular traps (NETs) from neutrophils and, although this is an immune defense mechanism, is associated with pro-inflammatory, metastatic, and thrombotic...
Jinglin, Jiao Lu, Gui-Hong Liu et al.· Translational Oncology· 0 citations
In this issue, Chen and colleagues show that MHC class II expression by pancreatic ductal adenocarcinoma (PDAC) malignant cells is a robust biomarker of both local production of IFNγ from lymphocytes and intact IFNγ signaling. RAS pathway inhibition can restore malignant cell IFNγ responsiveness in some patients, and m...
S. Dougan· Cancer immunology research· 0 citations
Highlights • MT-HCC exhibits more aggressive clinical and pathological features than CV-HCC.• Higher AFP, larger tumor size and more vascular invasion are observed in MT-HCC.• Distinct immune cell distribution patterns are identified in different tumor regions.• CD20+ B cells in the tumor margin correlate with favorabl...
Li-Xia Wu, Mei-Dan Li, Xue-Fang Wang et al.· Translational Oncology· 0 citations
Highlights • Single-cell transcriptomic profiling of multicenter pancreatic cancer radiotherapy cohorts identified PLPP2 as a key driver of radiotherapy resistance and immune microenvironment remodeling.• Random forest model identified PLPP2 as an important marker for promoting malignant progression, immune dysregulati...
Yi-Fei Wang, Parhat Kaysar, Yi-Jian Ma et al.· Translational Oncology· 0 citations
, and esophageal cancers, addressing this challenge from complementary clinical and translational perspectives. The contributions highlight three interconnected dimensions of individualized cancer care: the role of systemic inflammatory, nutritional, and body-composition parameters in perioperative and postoperative ri...
Xin-Xin Wang, J. Tang, Shuang Yang et al.· Frontiers in Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.
